Kidney Disease

1-16 of 148

Efficacy and Safety of Finerenone in Patients With Non-Diabetic CKD: Insight From FIND-CKD
Efficacy and Safety of Finerenone in Patients With Non-Diabetic CKD: Insight From FIND-CKD
Kidney Disease
Efficacy and Safety of Finerenone in Patients With Non-Diabetic CKD: Insight From FIND-CKD
prof. Hiddo Heerspink
- prof. Hiddo Heerspink
Finerenone Efficacy and Safety in Patients With CKD Regardless of Diabetes Status: Insights From the INFINITY Dataset
Finerenone Efficacy and Safety in Patients With CKD Regardless of Diabetes Status: Insights From the INFINITY Dataset
Kidney Disease
Finerenone Efficacy and Safety in Patients With CKD Regardless of Diabetes Status: Insights From the INFINITY Dataset
Rajiv Agarwal, MBBS, MD, FASN, BRCU
- Rajiv Agarwal, MBBS, MD, FASN, BRCU
Finerenone Subgroup Analyses in Patients With Glomerulonephritis
Finerenone Subgroup Analyses in Patients With Glomerulonephritis
Kidney Disease
Finerenone Subgroup Analyses in Patients With Glomerulonephritis
Brendon Neuen, MBBS, PhD
- Brendon Neuen, MBBS, PhD
Optimizing Patient Outcomes in CKD & T2D Care With CONFIDENCE
Optimizing Patient Outcomes in CKD & T2D Care With CONFIDENCE
Kidney Disease
Optimizing Patient Outcomes in CKD & T2D Care With CONFIDENCE
Rajiv Agarwal, MBBS, MD, FASN, BRCU
- Rajiv Agarwal, MBBS, MD, FASN, BRCU
Innovative Approaches to Managing CKM Syndrome and HFmrEF/HFpEF
Innovative Approaches to Managing CKM Syndrome and HFmrEF/HFpEF
CME/CE
Innovative Approaches to Managing CKM Syndrome and HFmrEF/HFpEF
Riccardo Maria Inciardi, MD, PhD
0.25 credits
- Riccardo Maria Inciardi, MD, PhD
0.25 credits
Finerenone does not alter vascular stiffness in patients with T2D and CKD
Finerenone does not alter vascular stiffness in patients with T2D and CKD
ESC Heart Failure 2025
Finerenone does not alter vascular stiffness in patients with T2D and CKD
Atsushi Tanaka, MD, PhD
- Atsushi Tanaka, MD, PhD
Novel Therapies in Managing Patients With Cardiovascular-Kidney-Metabolic Syndrome and Heart Failure
Novel Therapies in Managing Patients With Cardiovascular-Kidney-Metabolic Syndrome and Heart Failure
Broadcast Replay
Novel Therapies in Managing Patients With Cardiovascular-Kidney-Metabolic Syndrome and Heart Failure
Riccardo Maria Inciardi, MD, PhD; Cristina Gavina, MD, PhD
- Riccardo Maria Inciardi, MD, PhD
- Cristina Gavina, MD, PhD
- Giuseppe Galati, MD
Phase 3 study with oral semaglutide meets primary endpoint in high-risk T2D
Phase 3 study with oral semaglutide meets primary endpoint in high-risk T2D
ACC.25
Phase 3 study with oral semaglutide meets primary endpoint in high-risk T2D
Darren K. McGuire, MD
- Darren K. McGuire, MD
Expert opinion on the SOUL study results
Expert opinion on the SOUL study results
ACC.25
Expert opinion on the SOUL study results
Gina Lundberg, MD
- Gina Lundberg, MD
ns-MRAs: The Cardiovascular-Kidney-Metabolic Connection
ns-MRAs: The Cardiovascular-Kidney-Metabolic Connection
MinuteCE®
ns-MRAs: The Cardiovascular-Kidney-Metabolic Connection
Csaba P. Kovesdy, MD; Finnian R. McCausland, MD
1.25 program credits
- Csaba P. Kovesdy, MD
- Finnian R. McCausland, MD
1.25 program credits
ns-MRAs and eGFR Slope: The Kidney Perspective
ns-MRAs and eGFR Slope: The Kidney Perspective
MinuteCE®
ns-MRAs and eGFR Slope: The Kidney Perspective
Csaba P. Kovesdy, MD; Finnian R. McCausland, MD
1.25 program credits
- Csaba P. Kovesdy, MD
- Finnian R. McCausland, MD
1.25 program credits
Perspectives on CKM syndrome
Perspectives on CKM syndrome
AHA 2024
Perspectives on CKM syndrome
Javed Butler, MD
- Javed Butler, MD
Optimizing HF Outcomes Across the Spectrum: Emerging Evidence
Optimizing HF Outcomes Across the Spectrum: Emerging Evidence
MinuteCE®
Optimizing HF Outcomes Across the Spectrum: Emerging Evidence
Akshay S. Desai, MD; John McMurray, MD
1.25 program credits
- Akshay S. Desai, MD
- John McMurray, MD
1.25 program credits
Mastering MRA Monitoring: The Key to Success
Mastering MRA Monitoring: The Key to Success
MinuteCE®
Mastering MRA Monitoring: The Key to Success
Akshay S. Desai, MD; John McMurray, MD
1.25 program credits
- Akshay S. Desai, MD
- John McMurray, MD
1.25 program credits
Challenges of managing hyperkalemia in HF patients with CKD while maintaining RAAS inhibitor therapy
Challenges of managing hyperkalemia in HF patients with CKD while maintaining RAAS inhibitor therapy
MinuteCE®
Challenges of managing hyperkalemia in HF patients with CKD while maintaining RAAS inhibitor therapy
Gianluigi Savarese, MD
0.75 program credits
- Gianluigi Savarese, MD
0.75 program credits
A multidisciplinary clinical dialogue: Optimizing long-term goals: practical approaches to novel potassium binder use in cardiorenal care
A multidisciplinary clinical dialogue: Optimizing long-term goals: practical approaches to novel potassium binder use in cardiorenal care
MinuteCE®
A multidisciplinary clinical dialogue: Optimizing long-term goals: practical approaches to novel potassium binder use in cardiorenal care
James Burton, DM, FRCP; Aaron Wong, MD
0.75 program credits
- James Burton, DM, FRCP
- Aaron Wong, MD
0.75 program credits

Prev
1
2
3
…
9
10
Next

1/6